Starpharma Holdings Limited
Symbol: SPHRF
PNK
0.0774
USDMarket price today
-3.8414
P/E Ratio
-0.0396
PEG Ratio
31.89M
MRK Cap
- 0.00%
DIV Yield
Starpharma Holdings Limited (SPHRF) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 149.36 | 35.2 | 49.9 | 60.5 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 14.74 | 8.2 | 7.8 | 8.4 | ||||||||||||||||||||||||||
balance-sheet.row.inventory | 11.01 | 2.8 | 2.8 | 1.7 | ||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 14.82 | 0.9 | 0.1 | 0.1 | ||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 186.83 | 47.1 | 60.7 | 70.8 | ||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 19.29 | 5 | 5.5 | 2.5 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | -4.96 | -5 | -5.5 | -2.5 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 19.29 | 5 | 5.5 | 2.5 | ||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-assets | 206.13 | 52.1 | 66.2 | 73.2 | ||||||||||||||||||||||||||
balance-sheet.row.account-payables | 23.35 | 6.6 | 6.8 | 6.7 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 6.24 | 5.5 | 0.7 | 0.7 | ||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 14.96 | 2.8 | 7.5 | 0.5 | ||||||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 8.75 | 2.3 | 2.3 | 2.6 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 15.2 | 2.8 | 7.6 | 0.5 | ||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 13.17 | 2.8 | 4.2 | 1.2 | ||||||||||||||||||||||||||
balance-sheet.row.total-liab | 54.02 | 17.3 | 17.8 | 10.9 | ||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.common-stock | 962.81 | 240.7 | 240.7 | 240.6 | ||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | -923.22 | -234.2 | -218.6 | -202.4 | ||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 112.52 | 28.3 | 26.3 | 24.1 | ||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 152.11 | 34.8 | 48.4 | 62.3 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 206.13 | 52.1 | 66.2 | 73.2 | ||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-equity | 152.11 | 34.8 | 48.4 | 62.3 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 206.13 | - | - | - | ||||||||||||||||||||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-debt | 21.2 | 8.3 | 8.2 | 1.2 | ||||||||||||||||||||||||||
balance-sheet.row.net-debt | -128.16 | -26.9 | -41.7 | -59.3 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -12.59 | -15.6 | -16.2 | -19.7 | |||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 1.72 | 1.2 | 1.1 | 0.9 | |||||||||||||||||||||||
cash-flows.row.deferred-income-tax | -2.01 | -5.7 | -4.6 | -6.3 | |||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 2.06 | 2.1 | 2.2 | 3.7 | |||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -0.49 | -1 | -0.1 | -0.6 | |||||||||||||||||||||||
cash-flows.row.account-receivables | -1.26 | -1.3 | 0.6 | -2.4 | |||||||||||||||||||||||
cash-flows.row.inventory | 0.05 | 0.1 | -1.1 | -1.2 | |||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -0.1 | 0.3 | 2.9 | |||||||||||||||||||||||
cash-flows.row.other-working-capital | 0.71 | 0.2 | 0 | 0.1 | |||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 2.85 | 5.6 | 4.4 | 7.1 | |||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -9.53 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.25 | -0.6 | -0.8 | -0.2 | |||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0.01 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0.01 | 0 | 0 | 0 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -0.23 | -0.6 | -0.8 | -0.2 | |||||||||||||||||||||||
cash-flows.row.debt-repayment | -4.78 | -0.7 | -4 | -0.6 | |||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 48.9 | |||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | -1.9 | |||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -0.6 | |||||||||||||||||||||||
cash-flows.row.other-financing-activites | -5.5 | -0.7 | 7.2 | 0.6 | |||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -8.25 | -0.7 | 3.2 | 46.3 | |||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.1 | 0.1 | 0.2 | -0.8 | |||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -61.9 | -14.7 | -10.6 | 30.4 | |||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 61.36 | 35.2 | 49.9 | 60.5 | |||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 123.26 | 49.9 | 60.5 | 30.1 | |||||||||||||||||||||||
cash-flows.row.operating-cash-flow | -9.53 | -13.5 | -13.2 | -14.8 | |||||||||||||||||||||||
cash-flows.row.capital-expenditure | -0.25 | -0.6 | -0.8 | -0.2 | |||||||||||||||||||||||
cash-flows.row.free-cash-flow | -9.78 | -14.2 | -14 | -15.1 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 14.36 | 2.9 | 4.7 | 1.8 | ||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 7.48 | 1.7 | 2.8 | 0.8 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 6.88 | 1.2 | 1.9 | 1 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.research-development | 25.98 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 3.83 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.37 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.1 | 0.3 | 1.3 | ||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 27.5 | 25.9 | 19.6 | 23.4 | ||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 34.98 | 27.6 | 22.4 | 24.2 | ||||||||||||||||||||||||||
income-statement-row.row.interest-income | 1.58 | 1.3 | 0.2 | 0.4 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.37 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 1.62 | 1.4 | 0.3 | 1.3 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.1 | 0.3 | 1.3 | ||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 1.62 | 1.4 | 0.3 | 1.3 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 1.32 | 1.2 | 1.1 | 0.9 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -19.31 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.operating-income | -20.63 | -24.7 | -17.7 | -22.4 | ||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | -19.01 | -23.3 | -16.2 | -19.7 | ||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | -6.42 | -7.6 | -1.3 | -1.3 | ||||||||||||||||||||||||||
income-statement-row.row.net-income | -12.59 | -15.6 | -16.2 | -19.7 |
Frequently Asked Question
What is Starpharma Holdings Limited (SPHRF) total assets?
Starpharma Holdings Limited (SPHRF) total assets is 52086000.000.
What is enterprise annual revenue?
The annual revenue is 11209500.000.
What is firm profit margin?
Firm profit margin is 0.479.
What is company free cash flow?
The free cash flow is -0.024.
What is enterprise net profit margin?
The net profit margin is -0.877.
What is firm total revenue?
The total revenue is -1.436.
What is Starpharma Holdings Limited (SPHRF) net profit (net income)?
The net profit (net income) is -15638000.000.
What is firm total debt?
The total debt is 8272000.000.
What is operating expences number?
The operating expences are 25895500.000.
What is company cash figure?
Enretprise cash is 32131000.000.